Department of Gastroenterology, West China Hospital Sichuan University, Chengdu 610041, Sichuan Province, China.
World J Gastroenterol. 2020 Oct 21;26(39):5959-5969. doi: 10.3748/wjg.v26.i39.5959.
Due to the rapid progression and poor prognosis of esophageal cancer (EC), the early detection and diagnosis of early EC are of great value for the prognosis improvement of patients. However, the endoscopic detection of early EC, especially Barrett's dysplasia or squamous epithelial dysplasia, is difficult. Therefore, the requirement for more efficient methods of detection and characterization of early EC has led to intensive research in the field of artificial intelligence (AI). Deep learning (DL) has brought about breakthroughs in processing images, videos, and other aspects, whereas convolutional neural networks (CNNs) have shone lights on detection of endoscopic images and videos. Many studies on CNNs in endoscopic analysis of early EC demonstrate excellent performance including sensitivity and specificity and progress gradually from image analysis for classification to real-time detection of early esophageal neoplasia. When AI technique comes to the pathological diagnosis, borderline lesions that are difficult to determine may become easier than before. In gene diagnosis, due to the lack of tissue specificity of gene diagnostic markers, they can only be used as supplementary measures at present. In predicting the risk of cancer, there is still a lack of prospective clinical research to confirm the accuracy of the risk stratification model.
由于食管癌(EC)的快速进展和预后不良,早期 EC 的早期发现和诊断对改善患者预后具有重要价值。然而,早期 EC 的内镜检测,尤其是 Barrett 异型增生或鳞状上皮异型增生,具有一定难度。因此,对早期 EC 更有效检测和特征描述方法的需求,促使人们在人工智能(AI)领域开展了大量研究。深度学习(DL)在图像处理、视频等方面带来了突破,而卷积神经网络(CNN)则在检测内镜图像和视频方面大放异彩。许多关于早期 EC 内镜分析的 CNN 研究表明,其在敏感性和特异性方面表现出优异性能,并逐渐从图像分析分类进展到早期食管肿瘤的实时检测。当 AI 技术应用于病理诊断时,那些边界性的难以判断的病变可能会变得比以前更容易。在基因诊断方面,由于基因诊断标志物缺乏组织特异性,目前只能作为辅助手段。在预测癌症风险方面,仍缺乏前瞻性临床研究来确认风险分层模型的准确性。
World J Gastroenterol. 2020-10-21
United European Gastroenterol J. 2022-7
Dig Dis Sci. 2020-12
World J Gastroenterol. 2024-3-21
Cancer Res. 2021-7-1
World J Gastrointest Oncol. 2024-4-15
Biomed Opt Express. 2023-7-31
Int J Mol Sci. 2023-2-7
Front Oncol. 2023-1-4
Cancers (Basel). 2022-9-1
Gastroenterology. 2019-10-5
Gastrointest Endosc. 2020-2
Gastrointest Endosc. 2019-7-11